Every Form 4 that Axon Enterprise, Inc. (AXON) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow AXON and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AXON filings page.
Axon Enterprise president Joshua Isner reported a series of open-market stock sales. On March 10, he sold a total of 34,581 shares of Axon common stock in 18 separate transactions, at prices generally in the low-to-mid $500s per share. After these sales, he continued to hold 214,921 shares directly, so he remains a significant shareholder. The filing notes that many trades were executed in multiple lots, with reported prices representing weighted averages within specified intraday price ranges.
Axon Enterprise CEO Patrick W. Smith reported selling 10,000 shares of common stock in multiple open-market transactions on March 9, 2026. The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2025.
The trades were priced at reported weighted-average prices ranging from about $546.81 to $577.12 per share. After these transactions, Smith continues to hold 3,080,997 shares of Axon Enterprise common stock directly, indicating that the sale represents a small portion of his overall stake.
Axon Enterprise's Chief Revenue Officer, Cameron Brooks, reported an open-market sale of 1,221 shares of common stock. The shares were sold at an average price of $565.51 per share. After this transaction, Brooks directly holds about 57,545 shares, so the sale represents a small portion of his overall position. According to a footnote, the trade was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025, indicating it was scheduled in advance rather than timed opportunistically.
Axon Enterprise’s Chief Accounting Officer, Jennifer H. Mak, reported two stock transactions. On March 2, 2026, she completed an open-market sale of 1,500 shares of common stock at $573.45 per share. On March 3, 2026, 165.956 shares were disposed of to cover tax withholding from vesting restricted stock units, a non‑open‑market transaction. Following these transactions, she directly held a little over 12,000 shares of Axon common stock.
Axon Enterprise Chief Human Officer Elizabeth Reid Coughlin reported a routine share disposition related to taxes, not an open-market trade. On this Form 4, 489.608 shares of common stock were withheld at $579.09 per share to cover tax liabilities from vesting restricted stock units. After this tax-withholding disposition, she directly held 38,979.042 shares of Axon common stock.
AXON ENTERPRISE, INC. chief revenue officer Cameron Brooks reported a tax-related share disposition. On the reported date, 764.61 shares of common stock were withheld at $579.09 per share to cover his tax liability from vesting restricted stock units. After this withholding, he directly owned 58,766.39 shares of Axon common stock.
Axon Enterprise’s Chief Legal Officer Isaiah Fields reported recent stock transactions. On February 27, he completed open-market sales of 2,000 shares of common stock at weighted average prices of $534.9634 and $536.085, executed in multiple trades within narrow price ranges.
On March 3, an additional 775.028 shares were disposed of at $579.09 to cover tax withholding from the vesting of restricted stock units, rather than as an open-market sale. After these transactions, Fields directly held about 55,813 shares of Axon common stock.
AXON ENTERPRISE, INC. director Caitlin Elizabeth Kalinowski reported an open-market sale of common stock. On February 27, 2026, she sold 930 shares at a weighted average price of $535.3542 per share in multiple trades. After this transaction, she directly owns 3,585 common shares of Axon.
The sale price reflects a range of trade prices between $535.17 and $535.65, with the reported figure representing the weighted average sales price across those trades.
Axon Enterprise COO & CFO Brittany Bagley reported selling a total of 4,266 shares of Axon common stock in multiple open-market transactions on March 2, 2026 at prices above $550 per share. After these sales, she directly owned 99,235 shares of Axon common stock.
AXON ENTERPRISE, INC. chief executive officer and director Patrick W. Smith reported an open-market sale of 10,000 shares of common stock. The transaction occurred on February 25, 2026 at a price of $500.24 per share and was coded as a sale.
The filing states that this transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Smith on May 12, 2025. After this sale, Smith directly holds 3,090,997 shares of Axon common stock.
Axon Enterprise chief executive Patrick W. Smith reported a planned sale of company stock under a Rule 10b5-1 trading plan. On January 7, 2026, he sold Axon common shares in a series of open-market transactions at weighted average prices generally around $610–$625 per share, each coded as a sale of non-derivative common stock. The filing states these trades were executed pursuant to a Rule 10b5-1 plan adopted on May 12, 2025, indicating the sales were pre-arranged.
After completing the reported transactions, Smith directly beneficially owned 3,100,997 shares of Axon common stock. The prices disclosed for each line reflect weighted averages for multiple trades within specified price ranges, and Smith has undertaken to provide detailed trade breakdowns to regulators, the issuer, or shareholders on request.
Axon Enterprise, Inc. reported an insider equity award to its Chief Accounting Officer, Jennifer H. Mak. On 12/15/2025, she acquired 1,359.824 shares of common stock at a price of $0, reported as an acquisition under a company equity plan. Following this transaction, she beneficially owned 14,873.824 shares of Axon common stock in total.
The filing explains that these are time-vested restricted stock units granted under the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. The units are scheduled to vest in four equal installments of 339.956 shares each on March 3, 2028, May 31, 2028, August 31, 2028, and November 30, 2028, aligning her compensation with the company’s longer-term performance.
Axon Enterprise director Caitlin E. Kalinowski reported an insider ownership change involving a charitable gift of company stock. On 12/15/2025, she disposed of 180 shares of Axon Enterprise common stock in a transaction coded "G," which is described as a gift to a charitable donor-advised fund at a reported price of $0 per share. Following this transaction, she directly beneficially owns 4,515 shares of Axon Enterprise common stock.
Axon Enterprise's COO and CFO, Brittany Bagley, reported selling 2,000 shares of common stock on 12/11/2025 at a price of $580 per share.
Following this sale, she beneficially owns 103,501 shares directly, indicating she continues to hold a substantial stake in Axon while disposing of a small portion of her holdings.
Axon Enterprise director Jeri Williams reported selling small amounts of company common stock. On December 4, 2025, Williams sold 65 shares at a weighted average price of $550.2209 per share and 35 shares at a weighted average price of $551.3929 per share, for a total of 100 shares sold.
After these transactions, Williams directly beneficially owned 1,316 shares of Axon Enterprise common stock. Each sale was executed in multiple trades within narrow price ranges, and full trade details are available on request to the company, the SEC staff, or security holders.
Axon Enterprise, Inc. reported an equity award update for its President, Joshua Isner. On 11/13/2025, he acquired 67,910 shares of common stock at a price of $0, increasing his directly held beneficial ownership to 306,289 shares. These shares relate to performance-based restricted stock units (XSUs) originally granted on December 22, 2023 under the Axon Enterprise, Inc. 2024 eXponential Stock Plan.
The reported tranche of XSUs had its performance conditions certified as achieved by the company’s Compensation Committee on 11/13/2025 and is scheduled to vest on June 1, 2026, subject to Mr. Isner’s continued employment through that date. After vesting, the delivered shares will be subject to a minimum holding period until the earlier of December 31, 2030 or the vesting date of a subsequent XSU tranche, excluding any shares withheld or sold to cover taxes.
Axon Enterprise, Inc. officer Jeffrey C. Kunins reported an equity award event involving 20,618 shares of common stock. These shares relate to performance-based restricted stock units (XSUs) granted on December 22, 2023 under the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the third tranche performance conditions were certified as met on November 13, 2025.
The tranche is scheduled to vest on June 1, 2026, contingent on continued employment through that date. After vesting, the delivered shares are subject to a minimum holding period until the earlier of December 31, 2030 or the vesting of a later XSU tranche, excluding shares used to cover taxes. Following the reported transaction, Kunins beneficially owns 94,563 shares directly and 70,593 shares indirectly through an LLC of which he is the sole member.
Axon Enterprise, Inc. (AXON) reported that its Chief Executive Officer and director received 97,015 shares of common stock on 11/13/2025 through performance-based restricted stock units tied to tranche 3 of the 2024 CEO Performance Award. The Compensation Committee certified that the performance conditions were achieved on that date, triggering the award. These units are scheduled to vest on December 31, 2029, subject to the CEO’s continued employment. After this transaction, the CEO beneficially owns 3,120,997 shares of Axon common stock directly. Vested shares from each tranche are subject to a minimum holding period until the earlier of December 31, 2030 or the vesting of a subsequent tranche, other than shares withheld for taxes.
Axon Enterprise, Inc. (AXON) reported an insider equity award for its Chief Revenue Officer. On 11/13/2025, 15,810 shares of common stock were acquired at a price of $0, increasing the officer’s directly held stake to 60,278 shares. These shares relate to performance-based restricted stock units (XSUs) originally granted on April 1, 2024, for which the performance conditions for the third tranche were certified as achieved on that date.
The certified tranche will vest on October 1, 2026, subject to continued employment through that date. After vesting, the delivered shares are subject to a minimum holding period until the earlier of December 31, 2030 or the vesting of a subsequent XSU tranche, other than any shares withheld or sold to cover taxes.
Axon Enterprise, Inc. officer reports equity award vesting and tax withholding transactions. The company’s Chief Accounting Officer acquired 3,906 shares of Axon common stock on 11/13/2025 at a stated price of $0, reflecting performance-based restricted stock units from a 2023 grant under the 2024 eXponential Stock Plan, for which the third tranche performance conditions were certified on that date. On the same day, 2,277 shares were disposed of at $557.29 per share, representing shares withheld to cover the reporting person’s tax liability from vesting. After these transactions, the officer directly owned 16,632 shares of Axon common stock. The vested tranche is scheduled to fully vest on June 1, 2026, subject to continued employment, and the delivered shares will be subject to a minimum holding period until the earlier of December 31, 2030 or the vesting of a subsequent tranche, excluding shares used to cover taxes.
Axon Enterprise, Inc. reported an equity award event for its COO & CFO, Brittany Bagley. On 11/13/2025, she acquired 30,560 shares of Axon common stock at a price of $0, reflecting the certification of performance conditions for the third tranche of performance-based restricted stock units (XSUs) granted on December 22, 2023 under the Axon Enterprise, Inc. 2024 eXponential Stock Plan. These XSUs relate to a tranche whose performance goals were certified as achieved by the Compensation Committee on that date. After this transaction, she beneficially owns 121,652 shares of common stock directly. The tranche is scheduled to vest on June 1, 2026, subject to continued employment, and the shares delivered will be subject to a minimum holding period until the earlier of December 31, 2030 or the vesting of a subsequent XSU tranche, excluding shares used to cover taxes.
Axon Enterprise (AXON) insider transaction: On 11/10/2025, an officer serving as COO & CFO reported a sale of common stock under Form 4. The filing lists a disposition of 2,500 shares at $610 per share (transaction code “S”).
Following the sale, the insider beneficially owned 91,092 shares, held directly. The filing was made by one reporting person.
Axon Enterprise (AXON) disclosed that its Chief Executive Officer and Director sold 10,000 shares of common stock on 11/07/2025 in multiple transactions executed under a Rule 10b5-1 trading plan adopted on May 12, 2025. The trades were reported across price tranches, with individual weighted-average sale prices noted, ranging from $579.4601 to $610.58. Following these sales, the reporting person beneficially owns 3,023,982 shares, held directly.
Axon Enterprise (AXON) Chief Revenue Officer reported equity transactions tied to performance-based restricted stock units under the 2024 eXponential Stock Plan. On 08/28/2025, 31,620 shares were acquired at $0 upon certification that the first and second tranches met performance conditions, bringing beneficial ownership to 50,318 shares.
On 10/31/2025, 5,850 shares were disposed of at $711.34 to settle taxes from the first tranche vesting, leaving 44,468 shares beneficially owned. The first tranche vested on 10/01/2025; the second tranche will vest on 04/01/2026, each subject to continued employment. Shares delivered for each tranche are subject to a minimum holding period until the earlier of 12/31/2030 or the date a subsequent tranche vests, excluding shares withheld or sold for taxes. The filing notes it was submitted late due to an administrative error.